UL — Unilever Balance Sheet
0.000.00%
- $156.02bn
- $185.29bn
- €60.76bn
- 82
- 51
- 77
- 81
Annual balance sheet for Unilever, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,297 | 4,495 | 5,523 | 5,853 | 7,317 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,810 | 5,254 | 6,468 | 5,686 | 5,878 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16,157 | 17,401 | 19,157 | 17,902 | 19,194 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10,570 | 10,347 | 10,770 | 10,707 | 11,669 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 67,659 | 75,095 | 77,821 | 75,266 | 79,750 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 20,592 | 24,778 | 25,427 | 23,507 | 25,234 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 52,393 | 57,988 | 58,800 | 57,164 | 59,760 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 15,266 | 17,107 | 19,021 | 18,102 | 19,990 |
Total Liabilities & Shareholders' Equity | 67,659 | 75,095 | 77,821 | 75,266 | 79,750 |
Total Common Shares Outstanding |